Amerisourcebergen

Amerisourcebergen Current Assets

Current Assets of Amerisourcebergen (ABC) as of Nov 20, 2026.

Current Assets

-USD

Last updated:

Current Assets of Amerisourcebergen is 2026 - USD. Current Assets of Amerisourcebergen was 2025 - USD. It decreases by % lower compared to the previous year.

The Amerisourcebergen Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2013
14.39 B USD
Jan 1, 2014
16.80 B USD
Jan 1, 2016
22.82 B USD
Jan 1, 2017
24.32 B USD
Jan 1, 2018
25.89 B USD
Jan 1, 2019
29.28 B USD
Jan 1, 2021
40.07 B USD
Jan 1, 2022
41.12 B USD
The Amerisourcebergen Current Assets history
YEARCurrent AssetsYoY
41.12 BUSD+2.61%
40.07 BUSD+36.87%
29.28 BUSD+13.07%
25.89 BUSD+6.48%
24.32 BUSD+6.58%
22.82 BUSD+35.81%
16.80 BUSD+16.72%
14.39 BUSD+32.86%
10.83 BUSD-3.05%
11.17 BUSD+3.97%
10.75 BUSD+7.97%
9.95 BUSD+14.97%
8.66 BUSD-6.00%
9.21 BUSD+1,368.94%
627.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amerisourcebergen Stock analysis

What does Amerisourcebergen do? AmerisourceBergen Corp is a global healthcare company that offers a variety of products and services to its customers. It was founded in 2001 through the merger of AmeriSource Health Corp and Bergen Brunswig Corp. The company's business model is based on providing products, services, and technologies for various areas of the healthcare industry, including pharmacy, biotechnology, healthcare services, and retail. AmerisourceBergen Corp has three main business segments: Pharmaceutical Distribution Services, Provider Services, and Pharmaceutical Manufacturer Services. The pharmaceutical distribution service provides fast and reliable delivery of drugs and medical devices to pharmacies, wholesalers, and healthcare facilities. The provider service helps patients get the right medications and offers clinical services to medical facilities. The pharmaceutical manufacturer distribution provides support to its customers in the manufacturing, quality control, and marketing of drugs. The company also offers technology solutions that enable more patient-centered care and improve communication between doctors and patients. AmerisourceBergen Corp has extensive experience and expertise in the industry. It operates a wide network of branches and logistics centers worldwide to ensure its customers always receive the products and services they need. The company offers a wide range of pharmaceutical products, specialized disease drugs, biosimilars, vaccines, and medical devices. It also provides services such as consulting on drug manufacturing and approval, as well as logistics, financial, marketing, and information technology services for its customers. Over the years, AmerisourceBergen Corp has received numerous awards for its outstanding performance in the healthcare industry. The company is known for its commitment to patient-centered care and its innovative solutions to healthcare supply chain issues. With a strong reputation for quality and customer satisfaction, AmerisourceBergen Corp remains one of the leading companies in the healthcare industry. Amerisourcebergen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amerisourcebergen stock

On Eulerpool you can find the complete historical development of Current Assets Amerisourcebergen since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Amerisourcebergen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Amerisourcebergen

All Key Metrics — Amerisourcebergen